135 related articles for article (PubMed ID: 23726899)
1. Non-prescribed use of substitution medication among German drug users--prevalence, motives and availability.
Schmidt CS; Schulte B; Wickert C; Thane K; Kuhn S; Verthein U; Reimer J
Int J Drug Policy; 2013 Nov; 24(6):e111-4. PubMed ID: 23726899
[No Abstract] [Full Text] [Related]
2. Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany.
Schulte B; Schmidt CS; Strada L; Götzke C; Hiller P; Fischer B; Reimer J
Int J Drug Policy; 2016 Mar; 29():57-65. PubMed ID: 26818083
[TBL] [Abstract][Full Text] [Related]
3. Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication.
Johnson B; Richert T
J Addict Dis; 2015; 34(1):1-17. PubMed ID: 25496247
[TBL] [Abstract][Full Text] [Related]
4. Opioid pharmacotherapy: Treatment, regimes, constructions and control.
Neale J
Int J Drug Policy; 2013 Nov; 24(6):e1-5. PubMed ID: 24075399
[No Abstract] [Full Text] [Related]
5. The politics of providing opioid pharmacotherapy.
Radcliffe P; Parkes T
Int J Drug Policy; 2013 Nov; 24(6):e6-10. PubMed ID: 24183331
[No Abstract] [Full Text] [Related]
6. Economic vulnerability of methadone maintenance patients: Implications for policies on co-payment services.
Tran BX; Phan HT; Nguyen LH; Nguyen CT; Nguyen AT; Le TN; Latkin CA
Int J Drug Policy; 2016 May; 31():131-7. PubMed ID: 26922633
[TBL] [Abstract][Full Text] [Related]
7. Misuse of Substitution Drugs in the Substitution-Based Therapy.
Bleckwenn M; Heister L; Weckbecker M; Weckbecker K; Mücke M
Eur Addict Res; 2016; 22(6):322-328. PubMed ID: 27504977
[TBL] [Abstract][Full Text] [Related]
8. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications.
Firestone M; Goldman B; Fischer B
Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256
[TBL] [Abstract][Full Text] [Related]
9. Increasing access to opioid maintenance treatment: the role of primary care in France.
Roux P; Lions C; Carrieri MP
Int J Drug Policy; 2015 Apr; 26(4):434-5. PubMed ID: 25683137
[No Abstract] [Full Text] [Related]
10. Examining structural violence in opioid pharmacotherapy treatment in Australia: sweating the "small stuff" in a liberal paradise.
Treloar C; Valentine K
Int J Drug Policy; 2013 Nov; 24(6):e11-3. PubMed ID: 23711673
[No Abstract] [Full Text] [Related]
11. The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.
Horyniak D; Dietze P; Larance B; Winstock A; Degenhardt L
Int J Drug Policy; 2011 Mar; 22(2):167-71. PubMed ID: 21112758
[TBL] [Abstract][Full Text] [Related]
12. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
[TBL] [Abstract][Full Text] [Related]
13. The role of the Chinese police in methadone maintenance therapy: a literature review.
Meng J; Burris S
Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719
[TBL] [Abstract][Full Text] [Related]
14. Barriers to opioid substitution treatment access, entry and retention: a survey of opioid users, patients in treatment, and treating and non-treating physicians.
Stöver H
Eur Addict Res; 2011; 17(1):44-54. PubMed ID: 20975276
[TBL] [Abstract][Full Text] [Related]
15. Sanctions against Iran and the impact on drug use and addiction treatment.
Shariatirad S; Maarefvand M
Int J Drug Policy; 2013 Nov; 24(6):636-7. PubMed ID: 23683411
[No Abstract] [Full Text] [Related]
16. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
[TBL] [Abstract][Full Text] [Related]
17. Categorising methadone: Addiction and analgesia.
Keane H
Int J Drug Policy; 2013 Nov; 24(6):e18-24. PubMed ID: 23768774
[TBL] [Abstract][Full Text] [Related]
18. Shouting through bullet-proof glass: some reflections on pharmacotherapy provision in one Australian clinic.
Crawford S
Int J Drug Policy; 2013 Nov; 24(6):e14-7. PubMed ID: 24007689
[TBL] [Abstract][Full Text] [Related]
19. The marketing of methadone: how an effective medication became unpopular.
Bruce RD
Int J Drug Policy; 2013 Nov; 24(6):e89-90. PubMed ID: 24246504
[No Abstract] [Full Text] [Related]
20. Prescription of analgesics to patients in opioid maintenance therapy: a pharmacoepidemiological study.
Fredheim OM; Borchgrevink PC; Nordstrand B; Clausen T; Skurtveit S
Drug Alcohol Depend; 2011 Jul; 116(1-3):158-62. PubMed ID: 21277710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
